|
|
Post by peppy on Nov 7, 2023 21:13:16 GMT -5
celo wrote; Midcap had to begin buy down as of Sept 1. We have had 1 month of buy down of the loan in the third quarter which amounted to 1,667,000 in the CASH FLOWS and FINANCING LIABILITIES. This will be a quarterly draw of 5 million or 20 million annually for the next 2 years. mnkd.proboards.com/post/256911Steve B handles interest expensive. I would enjoy seeing him work a calculator. Hopefully Steve will get rid of the debt. I did see that and I thought they were paying that with shares. If not why the increase in shares? Good point, thank you. |
|
|
|
Post by letitride on Nov 7, 2023 21:16:21 GMT -5
Best Qtr Conference call to date. Heard Mike mention Morgan Stanley toward end of Q&A ? something coming up?
|
|
|
|
Post by shake34 on Nov 7, 2023 21:20:44 GMT -5
Steve B. said next 3 to 4 quarters we would be right around breakeven. I don't understand why. Our revenues should continue to increase every quarter so why won't profits increase also? I get expenses go up with more volume but it shouldn't be a wash. I did hear him say there could be exchange issue with paying for insulin which could be difference of couple mil. I've seen some predictions we will be around 60 mil in revs for 4th quarter, I hope we're better than break even at 60. Seem like they are likely planning spending on pipeline and studies. They likely have lots of things they'd like to do, and do faster, but are prioritizing and pacing so that they hover right around breakeven in order to develop a sense of financial stability with roughly neutral cash flow for institutional investors. Thanks, that's probably right and they will use shares to pay debt probably looks better that way, I hope. |
|
|
|
Post by peppy on Nov 7, 2023 21:22:11 GMT -5
I did see that and I thought they were paying that with shares. If not why the increase in shares? Good point, thank you. The increase in shares, sold to pay the debt. Weighted average shares - basic 268,732 Weighted average shares - diluted 323,770 55,000,000 shares well, well, well. schrts.co/xsJHSPfPI feel slow. |
|
|
|
Post by mytakeonit on Nov 7, 2023 21:26:58 GMT -5
letitride ... Morgan Stanley is E*Trade ... my brokerage house.
But, that's mytakeonit
|
|
|
|
Post by anderson on Nov 7, 2023 23:21:19 GMT -5
Great call overall. They were clear about the possibility of not having positive GAAP net earnings over the next few quarters because of fluctuating costs and unpredictable exchange rates related to contractual insulin purchases from Germany. For observers like us, Guidance will be influenced by watching exchange rates. Who knew? Mike sounded pretty positive about expectations related to INHALE study. I like the thinking behind increasing awareness by prescribers through involvement of study sites with endocrinology thought leaders. All this said, I only expect yawns from the market tomorrow. Did I actually hear Mike apologize for the SP behavior the past week? Wow. Feeling positive about prospects thru 2025.😊 GLTAL! FYI MNKD buys their insulin from Amphastar® Pharmaceuticals, Inc which bought the Merck’s API Manufacturing Business in Éragny-sur-Epte, France. So, it is still the Euro exchange rate we need to worry about. (clofazimine was from Germany) |
|
|
|
Post by cretin11 on Nov 7, 2023 23:31:57 GMT -5
Seem like they are likely planning spending on pipeline and studies. Thanks, that's probably right and they will use shares to pay debt probably looks better that way, I hope. Paying debt does look good. How high a price those shares fetch may have a bearing on how good it looks. |
|
|
|
Post by anderson on Nov 7, 2023 23:42:53 GMT -5
55,000,000 shares likely in RSUs and other stock based compensation. Been watching a lot of Form 144s, etc, fly by on the radar this quarter. Page 5 Show share BALANCE, JUNE 30, 2023 268,235k. 323,770k is the fully diluted value if all the debit is converted to shares(the ones with conversion options....ie senior notes and mann group). you can see that 362000 share were sold through the ATM this quarter. 13000 to Mann group to pay interest, 3.2 million for stock options and RSU 266000 employee stock purchase plan, and 36000 for Issuance of common stock from market price stock purchase plan whatever that is. to total of 4 million dilution this quarter. So yeah, they ran the ATM to pay for something. |
|
|
|
Post by celo on Nov 8, 2023 0:42:14 GMT -5
55,000,000 shares likely in RSUs and other stock based compensation. Been watching a lot of Form 144s, etc, fly by on the radar this quarter. Page 5 Show share BALANCE, JUNE 30, 2023 268,235k. 323,770k is the fully diluted value if all the debit is converted to shares(the ones with conversion options....ie senior notes and mann group). you can see that 362000 share were sold through the ATM this quarter. 13000 to Mann group to pay interest, 3.2 million for stock options and RSU 266000 employee stock purchase plan, and 36000 for Issuance of common stock from market price stock purchase plan whatever that is. to total of 4 million dilution this quarter. So yeah, they ran the ATM to pay for something. At 5.21 share the share conversion for the senior notes is about 42 million shares Another 3.5 million shares needed for the Mann group debt 4 million shares for the 4th quarter for all the same items that occurred in the third qtr. 42 and 3.5 and 4 = 49.5 or pretty close to the 51 million needed to cover the debts and the additional quarterly dilution |
|
|
|
Post by brentie on Nov 8, 2023 2:54:01 GMT -5
|
|
|
|
Post by LongMNKD on Nov 8, 2023 9:24:23 GMT -5
Congratulations everyone to a positive call. Any call that moves the price up and not down is great!
Here is my favorite part of the call!
I'm glad he acknowledged the share price just to show he is aware and would like to see it higher.
|
|
|
|
Post by phdedieu12 on Nov 8, 2023 9:28:46 GMT -5
Also maybe pointing out that there weren't any reasons for the last dip..... suggesting awareness of manipulation?  |
|
|
|
Post by ktim on Nov 8, 2023 9:42:51 GMT -5
Also maybe pointing out that there weren't any reasons for the last dip..... suggesting awareness of manipulation? The reason for the dip was the seeming slowing of growth in Tyvaso DPI revenue when UTHR reported. That's the more than obvious reason. As you surely could tell from seeing posts here, expectations were for continued growth as fast or faster than previous quarters. Expectations disappointed lead to share price decline. And Mike apparently said they'll be hovering around breakeven for next few quarters (I haven't yet been able to listen to call). That's basically telling would be investors they have plenty of time to earn money elsewhere and still catch any big share increase in MNKD at a later time. |
|
|
|
Post by standup on Nov 8, 2023 9:55:25 GMT -5
Also maybe pointing out that there weren't any reasons for the last dip..... suggesting awareness of manipulation? The reason for the dip was the seeming slowing of growth in Tyvaso DPI revenue when UTHR reported. That's the more than obvious reason. As you surely could tell from seeing posts here, expectations were for continued growth as fast or faster than previous quarters. Expectations disappointed lead to share price decline. And Mike apparently said they'll be hovering around breakeven for next few quarters (I haven't yet been able to listen to call). That's basically telling would be investors they have plenty of time to earn money elsewhere and still catch any big share increase in MNKD at a later time. No offense, but that's a recipe for missing the boat. |
|
|
|
Post by ktim on Nov 8, 2023 10:22:08 GMT -5
The reason for the dip was the seeming slowing of growth in Tyvaso DPI revenue when UTHR reported. That's the more than obvious reason. As you surely could tell from seeing posts here, expectations were for continued growth as fast or faster than previous quarters. Expectations disappointed lead to share price decline. And Mike apparently said they'll be hovering around breakeven for next few quarters (I haven't yet been able to listen to call). That's basically telling would be investors they have plenty of time to earn money elsewhere and still catch any big share increase in MNKD at a later time. No offense, but that's a recipe for missing the boat. Most professional investors don't feel they have to try to catch every single boat... and waiting for one particular one with dead money for years on end simply isn't in the smart money play book. I've been invested in MNKD since before the CRL.. not wanting to miss the boat. And while I now have made some overall profit, if I were to calculate an annual rate of return it would be pretty awful, trailing the dividend rate of many stable blue chips, and trailing the total S&P returns by a mile. Still waiting for the dreamboat to get out of the harbor. Unless Mike's comment about next few quarters turns out to be under promise and significantly over deliver, there isn't going to be any buying excitement near term, IMHO. And there is no track record to make investors feel Mike is an under promise over deliver CEO. |
|
